Category Archives: Hormone Replacement Therapy

After losing 60 pounds in the fall of 2009, Dave Smith figured his energy level would improve. Related Content & Coverage ‘LOW T' SYMPTOMS Some men have a lower-than-normal testosterone level without signs or symptoms. For others, low testosterone may cause: - Changes in sexual function. This may include reduced sexual desire, fewer spontaneous erections - such as during sleep - and infertility. - Changes in sleep patterns. Sometimes low testosterone causes insomnia or other sleep disturbances. - Physical changes. Various physical changes are possible, including increased body fat, reduced muscle bulk and strength, and decreased bone density. Swollen or tender breasts and hair loss are possible. You may experience hot flashes and have less energy than you used to. - Emotional changes. Low testosterone may contribute to a decrease in motivation or self-confidence. You may feel sad or depressed, or have trouble concentrating or remembering things. It's important to note that some of these signs and symptoms are a normal part of aging. Others can be caused by various underlying factors, including medication side effects, thyroid problems, depression and excessive alcohol use. A blood test is the only way to diagnose a low testosterone level. Source: Mayo Clinic He … Continue reading →

DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/9c3351/medical_devices_an) has announced the addition of the "Medical Devices and Equipment Market in Iran" report to their offering. “Medical Devices and Equipment Market in Iran” Iran Medical Equipment: A comprehensive report on Iran's Medical Equipment & Hospital Supplies, suitable for the manufacturers and distributors who would like to enter and/or expand in the market. The report includes data and statistics on imported and locally manufactured equipment/products as well as information on how to participate in tenders and projects. The 5 major categories covered are: 1. Diagnostic imaging system 2. Artificial Internal Organ Apparatus & Clinical Equipment 3. Clinical test equipment (including measuring and monitoring system) 4. Therapeutic Equipment 5. Hospital Supplies Key Topics Covered: Introduction About the Report Product Categories under Investigation Country Overview Healthcare Policy and System Government Policy Briefing of Medical and Insurance System Public Private Overview of Medical Equipment Market Market Size and Forecast Import Trends Patterns of Best Selling Products Status of Foreign Companies/Products Tier1 Brands Others Main Projects/Plans Public Sector Private Sector Key Basic Information in Order to Penetrate into the Market Market Characteristics Distribution System Procurement Method Market Entry Method Main Events Trade Fairs and Their Effectiveness Other Tender Opportunities Import/Sales … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/2dd8e6/hormone_replacemen) has announced the addition of the "Hormone Replacement Therapy (HRT) - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets. The Report Profiles 42 Companies Including Many Key and Niche Players Such As: Bayer HealthCare Pharmaceuticals, Inc. Besins Healthcare SA Hisamitsu Pharmaceutical Co. Inc. Noven Pharmaceuticals Inc. Mylan Canada Novartis AG Novo Nordisk A/S Orion Corporation Pfizer Inc. Wyeth Pharmaceuticals Inc. Rottapharm SpA Teva Pharmaceutical Industries Ltd. Thramex Warner Chilcott Watson Pharmaceuticals Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources. Key Topics Covered: 1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 2. INDUSTRY OVERVIEW 3. MARKET TRENDS 4. PRODUCT OVERVIEW 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT KEY PLAYERS 7. GLOBAL MARKET PERSPECTIVE 8. THE UNITED STATES 9. CANADA 10. EUROPE 11. ASIA-PACIFIC 12. REST OF WORLD … Continue reading →

Wall Street Executives and soccer moms alike are visiting AntiAgingMedicine.md or TestosteroneReplacementTreatment.com and learning how Dr. Lionel Bissoon, D.O has helped thousands of his patients look & feel their best with testosterone replacement therapy. New York, NY (PRWEB) February 16, 2012 As people age, there are physical changes that take place in the body. These changes can be significant and life changing. For years, men and women had to suffer in silence from decline in testosterone, PMS, menopause and weight gain. However, hormone therapy has transformed millions of people’s lives. Dr. Lionel Bissoon a world-renowned expert on the use of hormone replacement therapy has discovered effective treatments for these hormone-related medical conditions and founded TestosteroneReplacementTreatment.com and AntiAgingMedicine.md so that people could learn more and improve their lives. Dr. Lionel Bissoon, a world-renowned expert on the use of hormone replacement therapy, has treated tens of thousands of men and women for decades. His peers highly praise him as a leader in Testosterone Replacement Treatment. He is a nationally recognized trailblazer for improving the lives of tens of thousands of men and women and a leading voice in the hormone therapy community. Dr. Bissoon recently featured in the prestigious Financial Times regarding … Continue reading →

BATON ROUGE, LA (WAFB) - After breast cancer treatment, many women suffer from hot flashes and night sweats, but a type of "talk therapy" might relieve these symptoms for some women, British researchers suggest. In a new study, women who received this form of psychotherapy, known as cognitive behavioral therapy, had reduced their symptoms by half within six months. "Hot flashes and night sweats are distressing symptoms, which cause social embarrassment and sleep problems, and they are challenging to treat, especially for women who have had breast cancer" because hormone replacement therapy is generally not recommended for these women, explained lead researcher Myra Hunter. According to background information in the study, which is published in the Feb. 15 online edition of The Lancet Oncology, 65 percent to 85 percent of women have hot flashes after breast cancer treatment. Group cognitive behavioral therapy is a safe and effective treatment for women who have hot flashes and night sweats following breast cancer treatment, Hunter said, with additional benefits to mood, sleep and quality of life. "The women in this trial reported frequent and problematic symptoms and relatively low quality of life," said Hunter, a professor of clinical health psychology at King's College … Continue reading →

TUESDAY, Feb. 14 (HealthDay News) -- After breast cancer treatment, many women suffer from hot flashes and night sweats, but a type of "talk therapy" might relieve these symptoms for some women, British researchers suggest. In a new study, women who received this form of psychotherapy, known as cognitive behavioral therapy, had reduced their symptoms by half within six months. "Hot flashes and night sweats are distressing symptoms, which cause social embarrassment and sleep problems, and they are challenging to treat, especially for women who have had breast cancer" because hormone replacement therapy is generally not recommended for these women, explained lead researcher Myra Hunter. According to background information in the study, which is published in the Feb. 15 online edition of The Lancet Oncology, 65 percent to 85 percent of women have hot flashes after breast cancer treatment. Group cognitive behavioral therapy is a safe and effective treatment for women who have hot flashes and night sweats following breast cancer treatment, Hunter said, with additional benefits to mood, sleep and quality of life. "The women in this trial reported frequent and problematic symptoms and relatively low quality of life," said Hunter, a professor of clinical health psychology at King's … Continue reading →

Background Hot flushes and night sweats (HFNS) affect 65—85% of women after breast cancer treatment; they are distressing, causing sleep problems and decreased quality of life. Hormone replacement therapy is often either undesirable or contraindicated. Safe, effective non-hormonal treatments are needed. We investigated whether cognitive behavioural therapy (CBT) can help breast cancer survivors to effectively manage HFNS. Methods In this randomised controlled trial, we recruited women from breast clinics in London, UK, who had problematic HFNS (minimum ten problematic episodes a week) after breast-cancer treatment. Participants were randomly allocated to receive either usual care or usual care plus group CBT (1:1). Randomisation was done in blocks of 12—20 participants, stratifying by age (younger than 50 years, 50 years or older), and was done with a computer-generated sequence. The trial statistician and researchers collecting outcome measures were masked to group allocation. Group CBT comprised one 90 min session a week for 6 weeks, and included psycho-education, paced breathing, and cognitive and behavioural strategies to manage HFNS. Assessments were done at baseline, 9 weeks, and 26 weeks after randomisation. The primary outcome was the adjusted mean difference in HFNS problem rating (1—10) between CBT and usual care groups at 9 weeks after … Continue reading →

In this randomised controlled trial, the authors recruited 96 women from breast clinics in London, UK, who had problematic HFNS (minimum ten problematic episodes a week) after breast-cancer treatment. Participants were randomly allocated to receive either usual care (49) or usual care plus group CBT (47). Group CBT comprised one 90 min session a week for 6 weeks, and included psycho-education, paced breathing, and cognitive and behavioural strategies to manage HFNS. Assessments were done at baseline, 9 weeks, and 26 weeks after randomisation. The primary outcome was the adjusted mean difference in HFNS problem rating (1-10) between CBT and usual care groups at 9 weeks after randomisation. Usual care is having access to nurses and oncologists, as well as survivorship telephone support programmes and cancer support services. The authors found that group CBT significantly reduced HFNS problem rating at 9 weeks after randomisation compared with usual care. Encouragingly, these improvements were maintained at 26 weeks. Scores out of 10 for CBT declined from an initial average of 6.5 to 3.5 at 9 weeks (46% reduction) and to 3.1 at 26 weeks (52% reduction); equivalent usual care scores were 6.1, 5.0 and 4.6 (representing reductions of 19% and 25%). The authors … Continue reading →

05-12-2010 10:01 Comment and Subscribe, TELL YOUR FRIENDS! As we all know, one possible step in transition is beginning Hormone Replacement Therapy, or HRT There are so many myths about what happens when you are on hormones. Maybe not myths so much but because There are so many different ways to prescribe hormones, you have so many different outcomes. MOST importantly, what occurs will be different for everyone! No one will react the same! So I cover the general things I have felt while being on HRT for 8 months, these are just my experiences- Not intended to diagnose or take the place of consulting a doctor. I am not going to include what I take or how I take it because I am not a doctor nor would want someone to take unsafe measures with hormones. I believe you at least need to consult a certified physician at some point when on hormones. So that you can get a recommended plan and dosage! I hope this video is helpful! PLEASE SHARE YOUR EXPERIENCES OR MAKE A VIDEO COMMENT! Send messages to http://www.youtube.com Follow me on Twitter http://www.twitter.com Originally posted here: 8 Months on HRT! WHAT TO EXPECT! M to … Continue reading →

Once again we are returning to the question of whether menopausal hormone replacement therapy (HRT) increases breast cancer risk. The recent issue of Journal of Family Planning and Health Care contains an article by two researchers who argue that the data used in the previously reported Million Women Study? is too flawed to support its widely-heralded finding that HRT use increases breast cancer risk. The Million Women Study is an observational study that found that women who used estrogen and progestin had an increased risk of developing breast cancer. It is well understood that epidemiologic studies like the Million Women Study can only prove correlations, and not cause and effect. In fact, there are several observational studies that supported the use of HRT to prevent heart disease, a finding that was not born out when randomized trials were done. Moreover, the Million Women Study is not the only study to come to this conclusion, nor is it the key study that most researchers point to when talking about the risks associated with HRT. That study is the Women's Health Initiative, a randomized placebo-controlled trial that was specifically designed to measure the benefits and risks of menopausal hormone therapy -- and … Continue reading →